Julie B. Feder

Julie B. Feder

Former Chief Financial OfficeratAura Biosciences· In proxies 2023–2024

Pay in FY2024+7% from the year before · Aura Biosciences stock -7.2% the same year

Julie B. Feder was paid $2.0M in FY2024 (Dec), up 7%. Aura Biosciences stock fell 7.2% that year.

Pay$100 in the stock at the end of FY22 → $78
Pay is from the Summary Compensation Table of each Aura Biosciences proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Aura BiosciencesPublic company · 3 yr
    • Former Chief Financial Officer2023 – Present · 3 yrStock in role -39%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?